Clinical Trials Logo

CLL, Relapsed clinical trials

View clinical trials related to CLL, Relapsed.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04512105 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

Start date: December 2, 2020
Phase: Phase 1
Study type: Interventional

This is a phase I, dose-escalation, open-label clinical trial determining the safety and tolerability of adding Pitavastatin to Venetoclax in subjects with chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). These are subjects who are newly diagnosed subjects with AML who are ineligible for intensive induction chemotherapy, relapsed/refractory CLL or newly diagnosed CLL.